靶向 CD19 CAR-T 细胞治疗的非 ICANS 神经毒性与运动及神经认知治疗中出现的不良事件:一例病例报告
Non-ICANS neurotoxicities CD19-directed CAR T-cell therapy and the emergence of movement and neurocognitive treatment-emergent adverse events: a case
63.0分
★★★☆☆
站内排序·非疗效
FRONTIER PAPERS
Non-ICANS neurotoxicities CD19-directed CAR T-cell therapy and the emergence of movement and neurocognitive treatment-emergent adverse events: a case
Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistence.
Trends in Nephrology: From nihilism to targeted treatment of antibody-mediated rejection.
Cellular therapy for multiple myeloma: what's now and what's next.
共 4 条
MEMBER ACCOUNT
登录成功会直接打开下一页。